UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037761
Receipt number R000043064
Scientific Title Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings
Date of disclosure of the study information 2019/08/21
Last modified on 2020/08/23 21:47:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings

Acronym

Glove stocking study for Decetaxel -induced peripheral neuropathy

Scientific Title

Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings

Scientific Title:Acronym

Glove stocking study for Decetaxel -induced peripheral neuropathy

Region

Japan


Condition

Condition

Prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To consider the hypothesis of compression therapy for patients who begin docetaxel therapy for prostate cancer with using surgical gloves and stockings for lower limbs to reduce blood flow in the extremities during administration of anticancer drugs prevent Docetaxel-induced peripheral neuropathy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Presence of peripheral neuropathy at the end of 10 courses
Grade 1 or higher is judged to be peripheral neuropathy, and Grade 0 or higher is judged to be no peripheral neuropathy based on the CTCAE ver 5.0.

Key secondary outcomes

Changes in the nails at the end of the 10 courses
Based on the CTCAE ver 5.0, the "Peripheral Nerve Damage and Nail Questionnaire" is used to evaluate Grade 1 or higher as nail damage and Grade 0 as no nail damage.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

:Double surgical gloves that are one size smaller than the appropriate size, wear them 30 minutes before docetaxel administration, and remove the gloves 30 minutes after docetaxel administration.
:Appropriate venous thrombus prevention stockings should be worn 30 minutes before docetaxel administration, and the stockings should be removed 8 hours after docetaxel administration.
:Other supportive care is optional.
:In principle, administration of prohibited drugs as described below is prohibited.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

1) Prostate cancer patients with docetaxel therapy
2) Patients who are over 20 years old and who have obtained informed consent

Key exclusion criteria

1) Patients with peripheral neuropathy at the start of the study
2) Patients who have received medication that may cause peripheral neuropathy in the past.
3) Other patients who are judged inappropriate by the research doctor

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Takuma
Middle name
Last name Kato

Organization

Kagawa university

Division name

Department of Urology, faculty of medicine

Zip code

761-0793

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan

TEL

087-891-2202

Email

takuma_k@med.kagawa-u.ac.jp


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Kato

Organization

Kagawa university

Division name

Department of Urology, faculty of medicine

Zip code

761-0793

Address

Department of Urology, faculty of medicine

TEL

087-891-2202

Homepage URL


Email

takuma_k@med.kagawa-u.ac.jp


Sponsor or person

Institute

Kagawa university hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kagawa University School of Medicine Ethics Review Committee

Address

1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan

Tel

087-898-5111

Email

chiken@med.kagawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

香川大学医学部付属病院(香川県)


Other administrative information

Date of disclosure of the study information

2019 Year 08 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 04 Month 30 Day

Date of IRB

2019 Year 05 Month 27 Day

Anticipated trial start date

2019 Year 05 Month 27 Day

Last follow-up date

2022 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 08 Month 21 Day

Last modified on

2020 Year 08 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043064